Public Pathology Australia (and its predecessor, the National Coalition of Public Pathology) makes submissions to inquiries and reviews of governments and other bodies that affect public pathology as part of our advocacy activities.
Public Pathology Australia submissions include:
Australian Competition and Consumer Commission (ACCC) on the competition effects of proposed company mergers and acquisitions in the Australian pathology services market.
Submission on Sonic’s acquisition of Adelaide Pathology Partners, Nov 2015
Federal Department of Health on funding under the Medicare Benefits Schedule (MBS), on applications to the Medical Services Advisory Committee (MSAC) for listing on the MBS, on strengthening the provisions of the Health Insurance Act 1973 and its secondary legislation.
Submission on the proposed transfer of accreditation functions
Submission on the MBS Review – Pathology, Nov 2018
Submission on the MBS Review – Pathology Endocrine Tests Oct 2017
Submission on the MBS Review, Nov 2015
Submission on the Impact of Cervical Screening Changes, Apr 2015
Submission on Managing MBS Outlays, Jan 2015
Submission on Funding Parity Business Case
National Pathology Accreditation Advisory Council (NPAAC) on laboratory standards and requirements.
Submission on the NPAAC Requirements for Laboratories reporting tests for the National Cervical Screening Program (2nd edition) Dec 2018
Submission on the NPAAC Requirements for Validation of Self-Collected Vaginal Swabs for Use in the National Cervical Screening Program Dec 2018
Submission on the NPAAC Requirements for Transfusion Laboratory Practice Fourth Edition 2018 Dec 2018
Submission on the NPAAC Requirements For The Clinical Governance And Supervision Of Medical Pathology Laboratories Submission Nov 2016
Submission on the NPAAC Requirements for Laboratories Reporting Cervical Screening Submission Nov 2016
Submission on the NPAAC Communications Submission Aug 2015
Public Pathology Australia
Position Against Discrimination, Bullying and Sexual Harassment
Submission on Competitive Neutrality Policy Review
Therapeutic Goods Administration
Submission on the Proposal for the Regulation of IVD Companion Diagnostics Dec 2018
Senate Committees– such as the Community Affairs Committee on Gene Patents, a National Registration and Pathology Request Form Changes to give consumers greater choice of pathology provider and to the Legislative and Constitutional Committee on the Patent Amendment (Human Genes and Biological Materials) Bill 2010. Other submissions have been made on the National Cancer Screening Register Bill 2016 and National Cancer Screening Register (Consequential and Transitional Provisions) Bill 2016 Submission Sept 2016 and Submission to Senate Inquiry National Cancer Screening Register